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Delivering drug molecules into the cell is one of the major challenges in the process of drug development. In past, cell
penetrating peptides have been successfully used for delivering a wide variety of therapeutic molecules into various types
of cells for the treatment of multiple diseases. These peptides have unique ability to gain access to the interior of almost
any type of cell. Due to the huge therapeutic applications of CPPs, we have built a comprehensive database ‘CPPsite’, of cell
penetrating peptides, where information is compiled from the literature and patents. CPPsite is a manually curated data-
base of experimentally validated 843 CPPs. Each entry provides information of a peptide that includes ID, PubMed ID,
peptide name, peptide sequence, chirality, origin, nature of peptide, sub-cellular localization, uptake efficiency, uptake
mechanism, hydrophobicity, amino acid frequency and composition, etc. A wide range of user-friendly tools have been
incorporated in this database like searching, browsing, analyzing, mapping tools. In addition, we have derived various
types of information from these peptide sequences that include secondary/tertiary structure, amino acid composition and





Advances in proteomics and high-throughput assays have
led to the discovery of a large number of highly potent
therapeutic molecules. However, most of these molecules
do not reach the clinical trial stage due to their poor
delivery and low bioavailability. The plasma membrane of
eukaryotic cell is selectively permeable for exogenous mol-
ecules and large therapeutic molecules like DNA, proteins
and many drugs are impermeable due to their size or bio-
chemical properties. The intracellular delivery of these mol-
ecules has always been proven a major challenge for
scientific community. In order to overcome these problems,
many drug delivery techniques (viral and non-viral) have
been developed over the years (1, 2). Cell penetrating pep-
tides (CPPs) based method is one of the powerful tech-
niques used for delivering therapeutics/ drugs (3–6). It has
numerous advantages over the other delivery methods like
versatility, high efficiency, low toxicity.
Most of the CPPs have following features, short size
(10–30 amino acids), water soluble, often consists of basic
amino acids (arginine and lysine), and are mostly cationic or
amphipathic in nature (7–9). On the basis of their origin,
CPPs can be divided into three major categories; (i) protein
derived peptides (e.g. Tat, penetratin), (ii) chimeric peptides
(e.g. transportan) and (iii) synthetic peptides (10). These
peptides have been used to deliver various types of cargoes
such as proteins, peptide, siRNA, liposomes, nanoparticles
and drugs (11). In past, CPPs have been used in various clin-
ical applications particularly in cancer therapy (6, 12).
Recently, tumor homing CPPs (13) and activatable CPPs
(14) have been designed and used in the treatment and
diagnosis of cancer in vitro and in vivo. In addition, CPPs
have also been used in vaccine designing (15). Tat peptide
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gen in antigen presenting cells (16, 17).
In summary, CPPs have the tremendous potential, par-
ticularly in the field of therapeutics. Thus, there is a need
to compile these peptides from literature in order to under-
stand properties of these peptides. To the best of author’s
knowledge, no database or resource provides comprehen-
sive information about CPPs. In this study, we have made
a systematic attempt to collect and compile information
on CPPs from published literature, patents and other
resources. We hope this database will be very useful for
researchers working in the field of therapeutics.
Material and methods
Data collection and compilation
CPPs were collected and compiled from various resources.
It includes around 500 research articles and 50 patents.
These research articles and patents were extracted from
literature/patent databases using a combination of key-
words like cell-penetrating peptides, membrane permeable
peptides, protein transduction domain and membrane
transporting peptides. After careful readings of these
articles, we have scrutinized 83 research articles and 20 pa-
tents. From these articles and patents, only experimentally
validated CPP sequences and other relevant experimental
information like end modification, uptake efficiency,
uptake mechanism, sub-cellular localization and cell lines
used have been extracted and compiled. We have made
multiple entries of the CPPs, if similar peptides have been
tested against different cell types or similar peptides have
different end modifications. Therefore, total entries in
CPPsite are 843, but unique CPP sequences are 741.
Database architecture and web interface
It is built on an Apache HTTP Server 2.0.59 with
MySQL server. The front-end was developed using HTML,
PHP, JAVA script and the back-end was developed using
MySQL, a relational database management system. All
common gateway interface (CGI) and database interfacing
scripts were written in the PHP and PERL programming
language. Apache, MySQL and PHP technology were pre-
ferred as they were platform independent and open-source
software. The architecture of CPPsite database is shown
in Figure 1.
Organization of data
CPPsite is a manually curated database which provides
comprehensive information about each CPP. Data for
each peptide can be categorized as primary (e.g. peptide
sequence, PubMed ID (PMID) and experimental details) and
secondary data (e.g. secondary/tertiary structure, amino
acid composition, frequency and physicochemical proper-
ties). Each peptide is assigned a unique entry number,
and information is divided into different tables. Each
table provides unique information.
Primary data
Primary data contains general information of CPPs. All the
information is extracted manually from various resources,
Figure 1. Overall architecture of CPPsite database.
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Figure 1, database provides comprehensive information
on each peptide using more than 15 types of fields. Main
fields are described as follows: (i) Name: it represents the
name of the peptide used in literature; (ii) Sequence: it
contains amino acid sequence of CPP; (iii) Nature: it con-
tains the nature (e.g. cationic) of peptide; (iv) Family:
it represents the class of peptide (e.g. protein derived); (v)
uptake efficiency: It provides relative uptake efficiency of
CPP; (vi) uptake mechanism: it provides the mechanism of
internalization of CPP; (vii) end modification: it represents
the modification (e.g. FITC labeling/ amidation) at N-and
C-terminus of peptide; (viii) Cell lines: it represents the
cell lines used to validate the CPP.
Secondary data
In the past, it has been shown that internalization of
CPP depends on its structure (18) and nature of peptide.
Therefore, understanding of tertiary structure of these pep-
tides is a prerequisite. Since most of the peptide structures
are not available in Protein Data Bank (PDB) and existing
methods for predicting tertiary structure of protein are un-
suitable for predicting tertiary structure of peptides, we
have predicted tertiary structure of CPPs using software
PEPstr (19). PEPstr is a state of art method for predicting
structure of bioactive peptides. It is a de-novo method
which predicts beta-turns in a given peptide sequence
followed by secondary structure prediction by PSIPRED
and allocation of side-chain torsion angles by Dunbrack
Library. Energy minimization of the final model is done
using AMBER Version 6. In addition, secondary structures
of these peptides have also been predicted from predicted
tertiary structure using software DSSP (20). In our database,
we maintain both secondary and tertiary structure of each
peptide in PDB format.
In order to understand the nature of the peptide, it is
imperative to know the properties (pI, molecular weight,
amino acid frequency, hydrophobicity, charge, etc.) of each
peptide. Therefore, in-house PERL scripts have been used
for computing frequency and composition of each type of
amino acid residue in all the peptides. This information
is very useful to understand which residues/motifs are
preferred in CPPs. Apart from amino acid frequency and
composition; users may also want to know which types of
residues are preferred like charged, polar, hydrophobic,
etc. Therefore, we have computed frequency and compos-
ition of each class (aromatic, aliphatic, positive charge,
negative charge, neutral, polar and hydrophobic) of resi-
dues. This information is very useful to know which pep-
tides are dominated by positively charged residues.
We have also computed overall physicochemical properties
(hydrophobicity, hydrophilicity, molecular weight, iso-
electric point and net charge) of each peptide (21, 22). All
above information is stored in the database as secondary
data for analysis and browsing of peptides based on their
properties.
Implementation of tools
Currently, CPPsite contains 843 peptides, which have been
studied against almost 85 different cell lines. Experimental
details, PMID and patents information are also given for
every peptide. Many user-friendly tools/interfaces have
been integrated in CPPsite for extraction and analysis of
database. Following are the main tools provided with the
CPPsite database:
Search tools
CPPsite provides three search tools: simple search, advanced
search and peptide search. Simple search option allows
users to perform the search on any field of the database
like PubMed ID, CPP name, CPP sequence, origin, nature
of CPP (cationic and amphipathic), uptake mechanism,
etc. This option also allows displaying any or all fields of
databases for selected searched records. Advanced search
facility allows users to perform multiple queries at a time.
Under advanced search option, users can add any number
of queries for performing a search in the database. In add-
ition, it allows users to select conditions (e.g. AND & OR)
between queries. In summary, advanced search option
allows users to perform any type of data retrieval from
CPPsite. Peptide search option provides an option for
searching a peptide sequence in the database. It allows
two types of peptide search, (i) Containing peptide: it is
for searching user defined peptide sequence in CPPs, and
(ii) Exact search: it allows users to search CPPs, which are
100 percent identical to user’s peptide.
Browsing tools
We have designed powerful browsing facility that allows a
user to browse data on major fields that includes (i) chirality
of peptides; (ii) nature of peptides; (iii) family of peptides;
(iv) cell lines; (v) uptake mechanism and (iv) sub-cellular
localization. Chirality field includes five types of pep-
tides: peptides having all L-amino acids; all D-amino acids;
both L-&D-amino acids (mixed), and non-natural amino
acids (modified). Cyclic (C) peptides have also been included
in this field. As shown in Figure 2, it provides a number of
peptides for different types of CPPs, uptake mechanism,
sub-cellular localization and cell lines. It allows users to
browse on secondary data like (i) amino acid frequency,
(ii) amino acid composition, (iii) physicochemical property
frequency, (iv) physicochemical property composition and
(v) physicochemical property value (21, 22).
Retrieval and visualization of structures
In this database, predicted secondary and tertiary structure
of each peptide has been stored. Three interfaces have
been developed to extract structural information of CPPs.
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on their secondary structure composition (composition
H-helix, E-b strand, T-turn and C-coil). Second interface
allows users to search secondary structure segment in
secondary structure of CPPs.
Third interface is designed to browse tertiary structure of
CPPs. We have integrated Jmol (http://www.jmol.org) to
CPPsite that allows users to visualize 3D structure of CPPs.
Web-based tools
A number of web-based tools have been integrated in this
database to facilitate further analysis of peptides. A brief
description of these tools is as follows:
Blast search. We have integrated BLAST search tool (23)
that allows users to perform similarity based search against
CPPs. This option allows users to submit one or more pep-
tide sequences in FASTA format for performing BLAST
search against CPPs.
Smith–Waterman algorithm. In order to handle simi-
larity search effectively in case of small peptides, we have
integrated Smith–Waterman algorithm (24). This option
allows users to search CPPs in the database that are similar
to their peptides. Users can submit multiple peptide se-
quences in FASTA format.
Identical residues. In addition to BLAST and Smith–
Waterman algorithm, a simple algorithm has been inte-
grated called identical residues. It takes user defined
peptide sequence and aligns it with each CPP using over-
lapping approach (alignment without gap). It displays
query and target sequence with a number of identical resi-
dues in two peptides.
Peptide mapping. It allows users to map CPPs on their
peptide sequence. Users may submit protein or polypeptide
sequence on this page to identify segments that are iden-
tical to peptides in CPPsite.
Results
CPPsite is a unique collection of experimentally validated
843 CPPs and their derivatives in which 430 CPPs have been
collected from research publications, 172 CPPs from patents
and 241 CPPs from both research papers and patents.
The important feature of CPPsite is that it covers all possible
types of CPPs that consists of L-amino acids (777 peptides),
D-amino acids (34 peptides), both L & D amino acids
(11 peptides) and non-natural amino acids (21 peptides).
Few cyclic peptides (8 peptides) have also been incorpo-
rated (Figure 2). Most of the peptides (522) are protein
derived, 278 peptides are designed/synthetic and 43
Figure 2. Screenshot of major fields page of CPPsite.
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cationic (Arg rich) and 194 amphipathic peptides. Few of
them are antimicrobial (21 peptides) in nature (Figure 2).
CPPs have been validated for their cell penetration cap-
ability on variety of cell types in different conditions. In
CPPsite, CPPs have been found to be internalized into
more than 80 types of cell lines. As shown in Figure 3A,
most of the CPPs have been tested against HeLa cells (221
peptides), CHO (83 peptides), Human bowes melanoma
cell (54 peptides), Jurkat (47 peptides), EBTr (51 peptides)
and NIN-3T3 cells (80 peptides). CPPs have shown different
uptake mechanisms, which depend mainly on the size
(cargo i.e. peptides, proteins, fluorophores etc), tempera-
ture and cell types (5, 25, 26). In many cases, similar pep-
tides have shown different uptake mechanism at different
temperatures and at different concentrations (5, 25). In
CPPsite, 174 peptides displayed endocytic uptake mechan-
ism, while 184 peptides showed non-endocytic uptake
mechanism (Figure 3B). In non-endocytic route, peptides
have been found to be localized mainly into the cytoplasm
and nucleus, while in case of endocytic uptake, most of the
CPPs trapped into the endosomal vesicles. After escaping
from endosomes, these peptides released into the cyto-
plasm and subsequently reach to different locations inside
the cell. We have incorporated information on sub-cellular
localization of CPPs. 250 peptides localized both in the cyto-
plasm and nucleus after the internalization, 114 peptides
restricted to the cytoplasm/cytosol only, while 47 peptides
localized into the nucleus. 56 peptides showed punctuated
vesicular distribution. We have also incorporated infor-
mation on uptake efficiency of CPPs. In literature, data on
uptake efficiency of various CPPs has been presented in
comparison with some positive control (i.e. Tat, penetratin,
pVEC etc.). So, to make it simple, we have classified uptake
efficiencies of CPPs into three categories: Low (<25% rela-
tive to control); medium (between 26% and 75% relative
to control); and high (>75% relative to control).
We have computed average amino acid composition of
these peptides and observed that certain types of residues
(Arg, Lys, Leu and Ala) are more abundant (Figure 3C) in
CPPs. We have also computed the average amino acid com-
position of a set of large number of proteins extracted from
SwissProt and compared with amino acid composition of
CPPs. It was observed that Arg and Lys residues are more
Figure 3. Distribution of CPPs in CPPsite. (A) distribution of peptides based on cell lines, (B) distribution of CPPs based on uptake
mechanism, (C) average amino acid composition of peptides and (D) distribution of peptides based on secondary structure
composition.
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is in agreement with various studies, which showed that
positively charged residues are usually preferred in CPPs.
These cationic peptides interact with negatively charged
phosphates and sulfates on the surface of cell.
Since the structure of the CPPs play an important role in
internalization, we have computed secondary structure of
each peptide and classified peptides based on secondary
structure content. As shown in Figure 3D, most of the pep-
tides have <20% helix and b-strand content. Only limited
peptides have helix or b-strand content >80%. In case of
turn, it is observed that peptides having turns up to 60%
are equally distributed. In case of coil, a large number of
peptides have coil content in the range of 20–80%. This is
expected as it is difficult for a small peptide to maintain a
regular secondary structure.
Discussion
In the past few years, due to the huge therapeutic potential
of CPPs, a growing interest has been seen in CPP based
research. Most of the research on CPPs is currently being
focused on rational design of peptide based drugs and
diagnostics. All over the world, there is a healthy competi-
tion among the researchers to design novel and effective
CPPs. Since the discovery of Tat, thousands of research
papers have been published, illustrating the characteriza-
tion and therapeutic application of various novel CPPs.
This information is very useful for researchers/scientists to
design novel CPPs, and further characterization of the exist-
ing CPPs. Information about CPPs is scattered in literature,
it is difficult to access this useful information. CPPsite is a
first comprehensive database of its kind, which provides
both physicochemical and experimental information
related to CPPs.
CPPsite will be useful for researchers in many ways: (i)
users can check whether their peptides of interest are al-
ready reported as CPP or not; (ii) users can select the best
CPP from CPPsite with the desired efficiency and physico-
chemical properties for delivery; (iii) users can exploit struc-
tural information of CPP for docking or molecular dynamics
of the peptide-membrane complex. In addition, CPPsite
database will be helpful for developing prediction methods
for CPP. In conclusion, CPPsite, the freely available open
source database, would be very useful to scientific commu-
nity working in the field of peptide based drug discovery.
Update of CPPsite
The web server allows users to submit new entry of CPPs
on-line by filling HTML form. However, before including in
CPPsite, we will confirm the validity of new entry in order
to maintain the quality. Our team is also searching and
adding new entries of CPPs in database from published
literature. Attempts will be made to update this database
regularly.
Limitations and future developments
The unique feature of CPPsite is that it provides structural
information of all CPPs. We have predicted structure of
peptides that contain only natural amino acids. In CPPsite,
there are number of CPPs, which have non-natural or
D-amino acids. Since there is no method available presently,
which can predict the structure of peptides having non-
natural and D-amino acids, therefore, we have predicted
the structure of such peptides by removing non-natural
amino acids or by converting D-amino acids to L-amino
acids. One of the limitation of peptide based drug delivery
or therapy is their stability or half life in vivo. In future,
attempts will be made to provide half life of these CPPs.
Availability and requirements
CPPsite is available at http://crdd.osdd.net/raghava/cppsite/.
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